Literature DB >> 27805541

Inulin oligofructose attenuates metabolic syndrome in high-carbohydrate, high-fat diet-fed rats.

Senthil A Kumar1, Leigh C Ward2, Lindsay Brown1.   

Abstract

Prebiotics alter bacterial content in the colon, and therefore could be useful for obesity management. We investigated the changes following addition of inulin oligofructose (IO) in the food of rats fed either a corn starch (C) diet or a high-carbohydrate, high-fat (H) diet as a model of diet-induced metabolic syndrome. IO did not affect food intake, but reduced body weight gain by 5·3 and 12·3 % in corn starch+inulin oligofructose (CIO) and high-carbohydrate, high-fat with inulin oligofructose (HIO) rats, respectively. IO reduced plasma concentrations of free fatty acids by 26·2 % and TAG by 75·8 % in HIO rats. IO increased faecal output by 93·2 %, faecal lipid excretion by 37·9 % and weight of caecum by 23·4 % and colon by 41·5 % in HIO rats. IO improved ileal morphology by reducing inflammation and improving the density of crypt cells in HIO rats. IO attenuated H diet-induced increases in abdominal fat pads (C 275 (sem 19), CIO 264 (sem 40), H 688 (sem 55), HIO 419 (sem 32) mg/mm tibial length), fasting blood glucose concentrations (C 4·5 (sem 0·1), CIO 4·2 (sem 0·1), H 5·2 (sem 0·1), HIO 4·3 (sem 0·1) mmol/l), systolic blood pressure (C 124 (sem 2), CIO 118 (sem 2), H 152 (sem 2), HIO 123 (sem 3) mmHg), left ventricular diastolic stiffness (C 22·9 (sem 0·6), CIO 22·9 (sem 0·5), H 27·8 (sem 0·5), HIO 22·6 (sem 1·2)) and plasma alanine transaminase (C 29·6 (sem 2·8), CIO 32·1 (sem 3·0), H 43·9 (sem 2·6), HIO 33·6 (sem 2·0) U/l). IO attenuated H-induced increases in inflammatory cell infiltration in the heart and liver, lipid droplets in the liver and plasma lipids as well as impaired glucose and insulin tolerance. These results suggest that increasing soluble fibre intake with IO improves signs of the metabolic syndrome by decreasing gastrointestinal carbohydrate and lipid uptake.

Entities:  

Keywords:  C corn starch; CIO corn starch+5 % inulin oligofructose; H high-carbohydrate; HIO high-carbohydrate; IO inulin oligofructose; LPS lipopolysaccharide; LV left ventricular; LVIDs left ventricular internal diameter in systole; SBP systolic blood pressure; high-fat diet; high-fat+inulin oligofructose diet; Inulin; Metabolic syndrome; Oligofructose; Prebiotics; Rats

Mesh:

Substances:

Year:  2016        PMID: 27805541     DOI: 10.1017/S0007114516003627

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  17 in total

1.  Oligofructose restores postprandial short-chain fatty acid levels during high-fat feeding.

Authors:  Rachel K Meyer; Adelina I Lane; Savanna N Weninger; Taylor M Martinez; Archana Kangath; Daniel Laubitz; Frank A Duca
Journal:  Obesity (Silver Spring)       Date:  2022-07       Impact factor: 9.298

2.  Small intestinal metabolomics analysis reveals differentially regulated metabolite profiles in obese rats and with prebiotic supplementation.

Authors:  Rachel K Meyer; Megan A Bime; Frank A Duca
Journal:  Metabolomics       Date:  2022-07-23       Impact factor: 4.747

3.  When gut fermentation controls satiety: A PYY story.

Authors:  Rémy Burcelin
Journal:  Mol Metab       Date:  2016-11-21       Impact factor: 7.422

4.  The effects of dietary supplementation with inulin and inulin-propionate ester on hepatic steatosis in adults with non-alcoholic fatty liver disease.

Authors:  Edward S Chambers; Claire S Byrne; Annette Rugyendo; Douglas J Morrison; Tom Preston; Catriona Tedford; Jimmy D Bell; Louise Thomas; Arne N Akbar; Natalie E Riddell; Rohini Sharma; Mark R Thursz; Pinelopi Manousou; Gary Frost
Journal:  Diabetes Obes Metab       Date:  2018-09-16       Impact factor: 6.577

5.  Inulin Supplementation Reduces Systolic Blood Pressure in Women with Breast Cancer Undergoing Neoadjuvant Chemotherapy.

Authors:  Yizel Becerril-Alarcón; Saúl Campos-Gómez; Juan J Valdez-Andrade; Karen A Campos-Gómez; Diana Y Reyes-Barretero; Alejandra D Benítez-Arciniega; Roxana Valdés-Ramos; Alexandra E Soto-Piña
Journal:  Cardiovasc Ther       Date:  2019-07-01       Impact factor: 3.023

Review 6.  Role and Effective Therapeutic Target of Gut Microbiota in Heart Failure.

Authors:  Qiujin Jia; Hao Li; Huan Zhou; Xiaonan Zhang; Ao Zhang; Yingyu Xie; Yanyang Li; Shichao Lv; Junping Zhang
Journal:  Cardiovasc Ther       Date:  2019-11-16       Impact factor: 3.023

7.  Carrageenans from the Red Seaweed Sarconema filiforme Attenuate Symptoms of Diet-Induced Metabolic Syndrome in Rats.

Authors:  Ryan du Preez; Nicholas Paul; Peter Mouatt; Marwan E Majzoub; Torsten Thomas; Sunil K Panchal; Lindsay Brown
Journal:  Mar Drugs       Date:  2020-01-31       Impact factor: 5.118

8.  Desulfovibrio vulgaris, a potent acetic acid-producing bacterium, attenuates nonalcoholic fatty liver disease in mice.

Authors:  Ying Hong; Lili Sheng; Jing Zhong; Xin Tao; Weize Zhu; Junli Ma; Juan Yan; Aihua Zhao; Xiaojiao Zheng; Gaosong Wu; Bingbing Li; Bangxing Han; Kan Ding; Ningning Zheng; Wei Jia; Houkai Li
Journal:  Gut Microbes       Date:  2021 Jan-Dec

9.  Bifidobacteria or Fiber Protects against Diet-Induced Microbiota-Mediated Colonic Mucus Deterioration.

Authors:  Bjoern O Schroeder; George M H Birchenough; Marcus Ståhlman; Liisa Arike; Malin E V Johansson; Gunnar C Hansson; Fredrik Bäckhed
Journal:  Cell Host Microbe       Date:  2017-12-21       Impact factor: 31.316

Review 10.  Endocrine organs of cardiovascular diseases: Gut microbiota.

Authors:  Qiujin Jia; Yingyu Xie; Chunmiao Lu; Ao Zhang; Yanmin Lu; Shichao Lv; Junping Zhang
Journal:  J Cell Mol Med       Date:  2019-01-27       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.